Table 1.
MHC Class I Kb-binding, Peptide Competition, and TAP-dependent Transport of Seven wt p53 Peptides
| Kb binding peptides | UC50 | CC50 | IC50 | |||
|---|---|---|---|---|---|---|
| μg/ml | μg/ml | μg/ml | ||||
| aa 119–127: VMCYSPPL | 18 | 12 | 2.5 | |||
| aa 122–130: TYSPLNKL | 20 | 14 | 6 | |||
| aa 123–131: YSPPLNKLF | 4 | 0.5 | >100 | |||
| aa 127–134: LNKLFCQL | 4 | 2 | 7 | |||
| aa 158–166: AIYKKSQHM | 2.7 | 0.3 | 4.5 | |||
| aa 222–229: AGSEYTTI | 100 | 18 | 70 | |||
| aa 227–234: TTIHYKYM | 7 | 1.1 | 6 | |||
| SV9: FAPGNYPAL | 0.1 | 0.2 | ND |
Seven wt p53-derived were characterized in an MHC class I binding assay (column 1; reference 42), peptide competition cytotoxicity assay (column 2; reference 41), and TAP-dependent translocation assay (column 3; reference 44). (UC50) Peptide concentration resulting in 50% of the maximal upregulation of H-2Kb in the presence of the known H-2Kb-binding peptide Sendai virus NP 324–332 (61). (CC50) Peptide concentration that inhibits 50% of the maximal lysis by CTL clone BTM recognizing the reference peptide KSPWFTTL derived from the MCF1233 virus (39). (IC50) Concentration of competitor peptide that decreased the maximal amount of recovered glycosylated reporter peptide by 50% (44, 45). Indicated in bold are so-called anchor residues in the H-2Kb–binding motif described by Falk et al. (49).